Can I Take Creatine with Vardenafil (Levitra/Staxyn)?

Vardenafil and creatine do not compete for the same metabolic pathway, and no controlled study has reported a clinically meaningful interaction between them. Vardenafil is cleared mainly through hepatic CYP3A4 metabolism; creatine is not a CYP substrate and is handled through muscle uptake and renal filtration of its breakdown product, creatinine. The only interaction that matters in practice is a monitoring one: creatine raises serum creatinine independent of true kidney function, so a prescriber unaware of creatine use could misread a lab value. This is an established mechanism, but the exact size of the creatinine rise varies across studies and doses, so treat any specific number as an estimate pending confirmation from your pharmacist or prescriber.

Is there a direct pharmacological interaction?

No direct interaction has been established. Vardenafil is metabolized primarily by CYP3A4 (with minor contribution from CYP3A5 and CYP2C9). Creatine is absorbed in the gut, taken up into skeletal muscle, and converted to phosphocreatine to support ATP regeneration; it is not known to induce or inhibit CYP3A4, and it does not act on the nitric oxide/cGMP pathway that vardenafil affects. Because the two substances act through unrelated systems, there is no established pharmacokinetic basis for creatine to change vardenafil blood levels, or for vardenafil to change how creatine is absorbed or used by muscle.

The absence of a dedicated creatine-vardenafil trial is not itself alarming. Interaction studies are typically prioritized when there's a plausible mechanism (shared enzyme, transporter, or receptor) or a signal from case reports. Neither exists here, which is consistent with there being no interaction to find, but it also means this specific combination has not been directly tested in a trial designed for that purpose.

Why does creatine come up at all in the context of a PDE5 inhibitor?

The concern is a lab-interpretation issue, not a drug interaction in the strict sense. Creatine supplementation increases the amount of creatine in muscle, and a portion of that creatine spontaneously breaks down into creatinine, which is cleared by the kidneys and shows up as a higher number on a standard metabolic panel. Clinical trials in supplementing athletes have generally reported a modest rise in serum creatinine with regular use, without a corresponding drop in more specific kidney-filtration markers such as cystatin C. That pattern is consistent with creatine changing how much creatinine the body produces, rather than creatine damaging the kidneys. The exact magnitude reported across studies varies with dose and duration, and specific figures should be confirmed against the primary literature rather than taken as fixed from this page.

Vardenafil's own label addresses renal function directly: according to the FDA-approved prescribing information, no dose adjustment is needed for mild-to-moderate renal impairment, but caution and a lower recommended dose apply in severe impairment (very reduced creatinine clearance) (per the FDA-approved prescribing information for vardenafil). If a creatine-related creatinine bump pushes a borderline lab result into a worse-looking category, a prescriber who doesn't know about the supplement could apply more caution than is actually needed, or order additional workup. Disclosure solves this; it does not require stopping creatine.

What does the evidence actually establish, and what is still open?

Established:

• Vardenafil's principal metabolic pathway is hepatic CYP3A4, and its label describes renal impairment thresholds for dose adjustment. This comes from the FDA-approved prescribing information for vardenafil.
• Creatine supplementation raises serum creatinine in people who take it, a finding reported across multiple controlled studies in the sports nutrition literature.
• No case reports or interaction databases currently flag a vardenafil-creatine interaction.

Plausible but not rigorously quantified on this page:

• The precise average creatinine increase associated with different creatine doses and durations. Published figures vary by study population and protocol; a specific number should be verified against the primary trial rather than quoted as a fixed constant.
• Whether cystatin C-based kidney function testing is meaningfully more accurate than creatinine-based testing specifically in creatine users on vardenafil (this is a reasonable extrapolation from the general renal-function literature, not a study done in this population).

Not established:

• Any direct pharmacokinetic interaction between creatine and vardenafil.
• Any effect of creatine on erectile function, positive or negative.
• Long-term outcomes of combined creatine and PDE5-inhibitor use, since this specific combination has not been the subject of a dedicated trial.

Vardenafil interactions that are clinically real, for context

To put the creatine question in perspective, these are interactions the FDA label does treat as clinically important:

• Nitrates in any form (nitroglycerin, isosorbide products, nitrate-containing recreational drugs) are contraindicated with vardenafil because of the risk of severe blood pressure drops.
• Alpha-blockers (used for blood pressure or prostate symptoms) can have an additive blood-pressure-lowering effect with vardenafil; the label discusses dosing caution and timing.
• Strong CYP3A4 inhibitors (for example, ketoconazole, ritonavir) meaningfully increase vardenafil exposure, and some combinations are contraindicated or require a reduced vardenafil dose per the label.

Creatine does not fall into any of these categories. This distinction matters because it shows the label already identifies real supplement- and drug-interaction risks for vardenafil; creatine is not one of them.

Evidence-status interaction assessment: creatine and vardenafil

Who should be more cautious?

Most healthy adults taking vardenafil as needed and using creatine at standard doses are unlikely to encounter a meaningful problem from the combination. A few situations warrant more caution:

Existing chronic kidney disease. The FDA label restricts vardenafil to a lower dose in severe renal impairment. In this group, any additional creatinine load, even one that would be harmless in healthy kidneys, is harder to interpret and may warrant nephrology input before starting creatine.

Concurrent use of other agents that affect the kidney, such as regular NSAID use or nephrotoxic prescription drugs. None of these interact with vardenafil-creatine pharmacology directly, but they strengthen the case for renal monitoring generally.

Inadequate hydration during heavy training. Creatine increases water retention within muscle cells. Adequate fluid intake is standard advice for anyone using creatine, independent of vardenafil use.

What to tell your prescriber

A short disclosure is enough: something like, "I take creatine daily, so my creatinine on labs may run a bit higher than my true kidney function would suggest." This lets your prescriber interpret results correctly and decide whether a cystatin C-based test is worth adding. You generally do not need to stop creatine before routine bloodwork unless your prescriber specifically wants a supplement-free baseline for a targeted kidney workup, in which case follow their specific instructions on timing.

If you are starting vardenafil for the first time while already taking creatine, it is reasonable to ask whether a baseline renal panel is wanted, though most prescribers will not require one for men without kidney risk factors.

When to seek urgent care instead of just monitoring labs

Creatine and vardenafil use alone are not medical emergencies. Seek urgent evaluation if you experience sudden vision or hearing changes, an erection lasting more than four hours, chest pain, or fainting after taking vardenafil, or if you develop swelling, sharply reduced urination, or flank pain that could suggest a kidney problem unrelated to supplement-related lab noise. These symptoms need direct clinical assessment rather than self-monitoring.